増野弘幸

マスノヒロユキ | Masuno Hiroyuki

所属機関・部署：
職名：技術専門職員

研究分野 (1件)：薬系化学、創薬科学

競争的資金等の研究課題 (3件)：

論文 (33件)：

Ryosuke Ishida, Nagomi Kurebayashi, Hiroto Iinuma, Xi Zeng, Shuichi Mori, Masami Kodama, Takashi Murayama, Hiroyuki Masuno, Fumi Takeda, Masatoshi Kawahata, et al. A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment. European Journal of Medicinal Chemistry. 2023. 262. 115910-115910
Shigeru Yamada, Hiroyuki Masuno, Hiroyuki Kagechika, Aya Tanatani, Yasunari Kanda. A Novel Lithocholic Acid Derivative Upregulates Detoxification-Related Genes in Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids. BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2022. 45. 11. 1720-1724
Tsuyoshi Oikawa, Shinya Fujii, Shuichi Mori, Hiroyuki Masuno, Emiko Kawachi, Hiroyuki Kagechika. Structural Development of Silicon-Containing Retinoids: Structure-Activity Relationship Study of the Hydrophobic Pharmacophore of Retinobenzoic Acids Using Silyl Functionalities. CHEMMEDCHEM. 2022. 17. 12
Ayana Yoshihara, Haru Kawasaki, Hiroyuki Masuno, Koki Takada, Nobutaka Numoto, Nobutoshi Ito, Naoya Hirata, Yasunari Kanda, Michiyasu Ishizawa, Makoto Makishima, et al. Lithocholic Acid Amides as Potent Vitamin D Receptor Agonists. BIOMOLECULES. 2022. 12. 1
Shinya Fujii, Eriko Kikuchi, Honoka Suzuyama, Yuko Watanabe, Mari Ishigami-Yuasa, Hiroyuki Masuno, Takayasu Mori, Kiyoshi Isobe, Shinichi Uchida, Hiroyuki Kagechika. Structural Development of Salicylanilide-Based SPAK Inhibitors as Candidate Antihypertensive Agents. CHEMMEDCHEM. 2021. 16. 18. 2817-2822

MISC (2件)：

影近弘之, 藤井晋也, 増野弘幸. ホウ素クラスターを基盤としたビタミンDの構造展開(研究発表,第341回会議研究発表要旨,脂溶性ビタミン総合研究委員会). ビタミン. 2014. 88. 2. 106-106
K Yamamoto, H Masuno, S Yamada. Three-dimensional structure-activity relationship of vitamin D based on computational and synthetic chemistries. JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN. 2001. 59. 2. 131-141

特許 (5件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

増野 弘幸